Product Type: Market Research Report
Published by: Global Markets Direct
Published: November 2008
Product Code: R3480-7157Description South and Central America Surgical Sutures Market Size and Company Share Forecast to 2012
Summary
This report is an essential source for in-depth information and data relating to the South and Central America surgical sutures market. It also offers detailed and comprehensive coverage of market revenue and revenues broken down by the procedures types, volume, distribution and company share information; and latest news, financial deals in South and Central America
Scope
The report provides surgical sutures market information broken down into segments. Total revenues with segment breakdown by procedures, products sold by procedure types, end users, and average pricing. Market shares of all the key competitors. Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information. Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Reasons to buy
Gain a strong understanding of the surgical sutures market in Soth and Central America. Evaluate and compare the attractiveness of the market in the region. Identify growth segments and opportunities in each industry sector within the region. Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region. Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.Table of Contents - 1 Table Of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 3 Definitions of Markets Covered in the Report
- 3.1 Surgical Sutures
- 3.1.1 Absorbable Sutures
- 3.1.2 Non-Absorbable Sutures
- 4 Surgical Sutures in South and Central America
- 4.1 Surgical Sutures Overall Revenues (2000-2012)
- 4.2 Surgical Sutures Revenue by Segment and Procedures, 2007
- 4.3 Surgical Sutures Overall Volume (2000-2012)
- 4.4 Surgical Sutures Volume by Segments and Procedures, 2007
- 4.5 Surgical Sutures Average Price
- 4.6 Surgical Sutures Distribution Share (2006-2007)
- 4.7 Surgical Sutures Company Share (2006-2007)
- 5 Johnson & Johnson Company Profile
- 5.1 Company Overview
- 5.2 Business Overview
- 5.2.1 Consumer
- 5.2.1.1 Overview
- 5.2.1.2 Financials
- 5.2.1.3 Market View
- 5.2.1.4 Key Strategies
- 5.2.2 Medical Devices and Diagnostics
- 5.2.2.1 Overview
- 5.2.2.2 Financials
- 5.2.2.3 Market View
- 5.2.2.4 Key Strategies
- 5.2.3 Pharmaceutical
- 5.2.3.1 Overview
- 5.2.3.2 Financials
- 5.2.3.3 Market View
- 5.2.3.4 Key Strategies
- 5.2.4 Products
- 5.2.5 History
- 5.3 Value Chain Analysis
- 5.3.1 Manufacturing
- 5.3.1.1 In House Manufacturing
- 5.3.1.2 Outsourcing
- 5.3.2 Product Development
- 5.3.2.1 Regulatory Approvals
- 5.3.2.2 Clinical Trials
- 5.3.2.3 Research and Development
- 5.3.3 Sales and Marketing
- 5.3.3.1 Partnerships and Alliances
- 5.3.3.2 Licensing Agreements
- 5.4 SWOT Analysis
- 5.4.1 Johnson & Johnson Strengths
- 5.4.1.1 Strong presence in oncology market
- 5.4.1.2 Financial strength
- 5.4.1.3 Strong brand value
- 5.4.2 Johnson & Johnson Weaknesses
- 5.4.2.1 Few novel products
- 5.4.2.2 Underperformance of pharmaceutical division
- 5.4.2.3 Concentrated revenues
- 5.4.3 Johnson & Johnson Opportunities
- 5.4.3.1 Acquisitions
- 5.4.3.2 Growing U.S. market
- 5.4.3.3 Approval of Perzista
- 5.4.4 Johnson & Johnson Threats
- 5.4.4.1 Mergers and acquisitions
- 5.4.4.2 Increased competition due to patent expiry
- 5.4.4.3 Generic competition to Topamax
- 5.5 Revenue Analysis
- 5.5.1 Revenue by Segment
- 5.5.2 Revenue by Geography
- 5.6 Financial and Operational Review
- 5.6.1 Financial Statements
- 5.6.2 Financial Ratios
- 5.7 Locations and Subsidiaries
- 6 Tyco Healthcare/Kendall Company Profile
- 6.1 Company Overview
- 6.2 Business Overview
- 6.2.1 Products
- 6.2.2 History
- 6.3 Locations and Subsidiaries
- 7 B. Braun Melsungen AG Company Profile
- 7.1 Company Overview
- 7.2 Business Overview
- 7.2.1 Aesculap division
- 7.2.1.1 Overview
- 7.2.1.2 Financials
- 7.2.1.3 Market View
- 7.2.1.4 Key Strategies
- 7.2.2 B. Braun Avitum division
- 7.2.2.1 Overview
- 7.2.2.2 Financials
- 7.2.2.3 Market View
- 7.2.2.4 Key Strategies
- 7.2.3 Hospital Care division
- 7.2.3.1 Overview
- 7.2.3.2 Financials
- 7.2.3.3 Key Strategies
- 7.2.4 Out Patient Market (OPM) division
- 7.2.4.1 Overview
- 7.2.4.2 Financials
- 7.2.4.3 Market View
- 7.2.4.4 Key Strategies
- 7.2.5 Products
- 7.2.6 History
- 7.3 Value Chain Analysis
- 7.3.1 Manufacturing
- 7.3.1.1 In House Manufacturing
- 7.3.1.2 Outsourcing
- 7.3.2 Product Development
- 7.3.2.1 Regulatory Approvals
- 7.3.2.2 Clinical Trials
- 7.3.2.3 Research and Development
- 7.3.3 Sales and Marketing
- 7.3.3.1 Partnerships and Alliances
- 7.3.3.2 Licensing Agreements
- 7.4 SWOT Analysis
- 7.4.1 B. Braun Melsungen AG Strengths
- 7.4.1.1 L.I.F.E certification
- 7.4.1.2 Significant revenues
- 7.4.1.3 Worldwide existence
- 7.4.2 B. Braun Melsungen AG Weaknesses
- 7.4.2.1 High SG&A expenses
- 7.4.2.2 FDA warning letter
- 7.4.3 B. Braun Melsungen AG Opportunities
- 7.4.3.1 Acquisitions
- 7.4.3.2 Expansion of business
- 7.4.3.3 Broad product portfolio
- 7.4.4 B. Braun Melsungen AG Threats
- 7.4.4.1 Foreign exchange
- 7.4.4.2 Intense competition and change in technologies
- 7.5 Revenue Analysis
- 7.5.1 Revenue by Segment
- 7.5.2 Revenue by Geography
- 7.6 Financial and Operational Review
- 7.6.1 Financial Statements
- 7.6.2 Financial Ratios
- 7.7 Locations and Subsidiaries
- 7.8 B. Braun Melsungen AG Pipeline Products
- 7.8.1 Coroflex Please
- 7.8.1.1 Product Overview
- 7.8.1.2 Product Description
- 7.8.1.3 Product Status
- 7.8.1.4 Clinical Trials
- 7.8.1.5 Product Milestone
- 7.8.2 SeQuent Please
- 7.8.2.1 Product Overview
- 7.8.2.2 Product Description
- 7.8.2.3 Product Status
- 7.8.2.4 Clinical Trials
- 7.8.2.5 Product Milestone
- 8 Appendix
- 8.1 Global Markets Direct Research Methodology
- 8.2 Coverage
- 8.3 Secondary Research
- 8.4 Primary Research
- 8.5 Models
- 8.6 Forecasts
- 8.7 Expert Panels
- 8.8 Abbreviations
- 8.9 Currency Conversion
- 8.10 Contact Us
- 8.11 Disclaimer
- 1.1 List of Tables
- Table 1: Surgical Sutures, South & Central America, Revenues ($ mn), 2000-2012
- Table 2: Surgical Sutures, South & Central America, Revenues ($ mn) by Segment, Historic, 2000-2007
- Table 3: Surgical Sutures, South & Central America, Revenues ($ mn) by Segment, Forecast, 2007-2012
- Table 4: South & Central America, Revenue ($ mn) by Segments and Procedures, 2007
- Table 5: Surgical Sutures, South & Central America, Volume (Units), 2000-2012
- Table 6: Surgical Sutures, South & Central America, Volume (Units) by Segment, Historic, 2000-2007
- Table 7: Surgical Sutures, South & Central America, Volume (Units) by Segment, Forecast, 2007-2012
- Table 8: South & Central America, Volume (Units) by Segments and Procedures, 2007
- Table 9: Surgical Sutures, South & Central America, Average Price ($), Historic, 2000-2007
- Table 10: Surgical Sutures, South & Central America, Average Price ($), Forecast, 2007-20012
- Table 11: Surgical Sutures, South & Central America, Distribution Share by Revenue ($ mn), 2006-2007
- Table 12: Surgical Sutures, South & Central America, Company Share by Revenue ($ mn), 2006-2007
- Table 13: Johnson & Johnson, SWOT Analysis , 2007
- Table 14: Johnson & Johnson, Revenue by Segment, USD Million, 2003-2007
- Table 15: Johnson & Johnson, Revenue by Geography, USD Million, 2003-2007
- Table 16: Johnson & Johnson, Financial Statements, USD Million, 2003-2007
- Table 17: Johnson & Johnson, Financial Ratios, USD Million, 2003-2007
- Table 18: Johnson & Johnson, Subsidiaries
- Table 19: B. Braun Melsungen AG, SWOT Analysis , 2006
- Table 20: B. Braun Melsungen AG, Revenue by Segment, Euro Thousand, 2002-2006
- Table 21: B. Braun Melsungen AG, Revenue by Geography, Euro Thousand, 2002-2006
- Table 22: B. Braun Melsungen AG, Financial Statements, Euro Thousand, 2002-2006
- Table 23: B. Braun Melsungen AG, Financial Ratios, Euro Thousand, 2002-2006
- Table 24: B. Braun Melsungen AG, Subsidiaries
- Table 25: Abbreviations used in the Market Revenue Chapters
- Table 26: Currency Conversion from USD to Local Currency at 2007 Constant Rate
- 1.2 List of Figures
- Figure 1: Surgical Sutures, South & Central America, Revenues ($ mn), 2000-2012
- Figure 2: South & Central America, Surgical Sutures Market Value, Portfolio Analysis
- Figure 3: Surgical Sutures, South & Central America, Revenues ($ mn) by Segment, Historic, 2000-2007
- Figure 4: Surgical Sutures, South & Central America, Revenues ($ mn) by Segment, Forecast, 2007-2012
- Figure 5: South & Central America, Revenue ($ mn) by Segments and Procedures, 2007
- Figure 6: Surgical Sutures, South & Central America, Volume (Units) , 2000-2012
- Figure 7: South & Central America, Surgical Sutures, Volume (Units), Portfolio Analysis
- Figure 8: Surgical Sutures, South & Central America, Volume (Units) by Segment, Historic, 2000-2007
- Figure 9: Surgical Sutures, South & Central America, Volume (Units) by Segment, Forecast, 2007-2012
- Figure 10: South & Central America, Volume (Units) by Segments and Procedures , 2007
- Figure 11: Surgical Sutures, South & Central America, Company Share (%), 2007
- Figure 12: Johnson & Johnson, Value Chain Analysis
- Figure 13: B. Braun Melsungen AG, Value Chain Analysis
- Figure 14: Global Markets Direct Methodology
|
|